Capnocytophaga bacteraemia following rituximab treatment

Elisheva Pokroy-Shapira, Shachaf Shiber*, Yair Molad

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


A case is presented of Capnocytophaga bacteraemia, in a juvenile chronic arthritis ( JCA) patient receiving steroids, methotrexate and rituximab. This Gram-negative bacillus commonly found in dog saliva has been described to cause illness in immune compromised hosts such as oncology patients, those receiving cytotoxic or biological drugs, alcoholics or postsplenectomy. To the best of our knowledge, this is the first report of Capnocytophaga bacteraemia following rituximab treatment.

Original languageEnglish
JournalBMJ Case Reports
StatePublished - 2012
Externally publishedYes


Dive into the research topics of 'Capnocytophaga bacteraemia following rituximab treatment'. Together they form a unique fingerprint.

Cite this